Wegovy on the NHS

Wegovy on the NHS

  • Wegovy will be available on the NHS as part of a specialist weight management service for individuals with a BMI over 35 and will be accessible at select high street chemists through in-person visits and online consultations.
  • Wegovy will be prescribed for a maximum of 2 years under the NHS criteria. If someone doesn’t qualify for an NHS prescription, there are other options available, including private purchase.
  • Differences between semaglutide brand names: Novo Nordisk markets Ozempic for managing type 2 diabetes and reducing cardiovascular risks, while Wegovy is specifically designed for chronic weight management and weight loss purposes.

Can you get Wegovy on the NHS?

The National Institute for Health and Care Excellence (NICE) has drafted guidance recommending Wagovy as a prescription medication to target weight loss. Wegovy will be available on the NHS for those with a BMI over 35, type 2 diabetes, pre-diabetes, high blood pressure, dyslipidaemia (unbalanced or unhealthy cholesterol levels), obstructive sleep apnoea and heart disease. Wegovy will only be prescribed for a maximum of 2 years. The medication criteria will differ from a private prescription plan from the NHS, meaning if you don’t qualify for an NHS prescription, there are other options available. 

What if I don’t meet the NHS Criteria? 

If you do meet the NHS criteria, you can purchase it privately, the cost of Wegovy will depend on whether you are purchasing the pens outright, or through a service that offers Wegovy as part of a programme.

What are the differences between the different semaglutide brand names?

Novo Nordisk markets injectable semaglutide under two brand names: Ozempic and Wegovy. Ozempic is primarily utilised to manage type 2 diabetes and reduce the risk of major cardiovascular issues in specific patients. On the other hand, Wegovy is specifically designed for chronic weight management and facilitates weight loss efforts.

Further reading about Wegovy